|
Real-time Estimate
Cboe BZX
12:22:20 10/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 932.56 USD | +3.12% |
|
-3.00% | +20.81% |
| Market Cap | 9.07TCr 8.1TCr 7.45TCr 6.76TCr 13TCr 8,50600Cr 13TCr 89TCr 36TCr 4,55400Cr 34TCr 33TCr 14,34300Cr | P/E 2026 * |
15.3x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.36TCr 7.46TCr 6.86TCr 6.23TCr 12TCr 7,83400Cr 12TCr 82TCr 33TCr 4,19400Cr 31TCr 31TCr 13,21000Cr | EV / Sales 2026 * |
4.45x | EV / Sales 2027 * | 3.88x |
| Free-Float |
72.57% | Yield 2026 * |
0.42% | Yield 2027 * | 0.44% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Xetra
| RGO | End-of-day quote | |
|
Boerse Muenchen
| RGO | Real-time | |
|
London S.E.
| 0R2M | Delayed | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.49% | ||
| 1 week | -4.20% | ||
| Current month | -0.75% | ||
| 1 month | +23.36% | ||
| 3 months | +13.97% | ||
| 6 months | +29.20% | ||
| Current year | +19.31% |
| 1 week | 887.04 |  | 991.73 |
| 1 month | 743.57 | | 991.73 |
| Current year | 591.52 | | 991.73 |
| 1 year | 591.52 | | 991.73 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Sell | Chief Technology Officer | -4,147 | 0.0041% | ||
| 03/09/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 02/09/26 | Exercice | Director | 1,200 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.42% | -4.20% | +40.65% | +15.08% | 9.07TCr | |
| +4.19% | -0.44% | +45.32% | +137.56% | 1,20600Cr | |
| +2.25% | +4.04% | +49.40% | +90.94% | 66TCr | |
| +1.00% | +1.41% | +33.92% | +112.18% | 51TCr | |
| +2.77% | +0.98% | +43.81% | +68.46% | 38TCr | |
| +1.18% | -0.36% | +70.41% | +44.39% | 36TCr | |
| +0.29% | +1.48% | +30.59% | +58.32% | 31TCr | |
| +0.98% | +1.49% | +7.16% | +34.78% | 29TCr | |
| +1.00% | -0.46% | +43.15% | +75.46% | 25TCr | |
| +1.49% | -0.72% | +43.13% | +125.54% | 21TCr | |
| Average | +1.64% | -1.64% | +40.76% | +76.27% | 42.7TCr | |
| Weighted average by Cap. | +2.17% | -1.97% | +42.60% | +93.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.88TCr 1.68TCr 1.54TCr 1.4TCr 2.65TCr 1,76100Cr 2.72TCr 18TCr 7.36TCr 94TCr 7.05TCr 6.9TCr 2,96900Cr | 2.01TCr 1.8TCr 1.66TCr 1.5TCr 2.85TCr 1,88900Cr 2.92TCr 20TCr 7.89TCr 1,01100Cr 7.56TCr 7.4TCr 3,18500Cr |
| Net income | 642.63Cr 573.61Cr 527.82Cr 479.05Cr 907.86Cr 60TCr 930.4Cr 6.31TCr 2.52TCr 32TCr 2.41TCr 2.36TCr 1,01600Cr | 655.96Cr 585.51Cr 538.77Cr 488.98Cr 926.69Cr 61TCr 949.7Cr 6.45TCr 2.57TCr 33TCr 2.46TCr 2.41TCr 1,03700Cr |
| Net Debt | -716.8Cr -639.81Cr -588.74Cr -534.34Cr -1.01TCr -67TCr -1.04TCr -7.04TCr -2.81TCr -36TCr -2.69TCr -2.63TCr -1,13300Cr | -1.25TCr -1.12TCr -1.03TCr -933.1Cr -1.77TCr -1,17300Cr -1.81TCr -12TCr -4.9TCr -63TCr -4.7TCr -4.6TCr -1,97800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $932.63 | +3.13% | 3,29,438 |
| 06/26/06 | $904.35 | +0.16% | 11,22,872 |
| 05/26/05 | $902.90 | -2.98% | 14,07,351 |
| 04/26/04 | $930.67 | -4.39% | 13,95,270 |
| 03/26/03 | $973.36 | +1.26% | 12,00,307 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
